in circulating CD4 + CRTh2 + between EB and HV, or between EB and EA. The Th2 cells in airway (induced sputum) in EB subjects, EA subjects were both significantly higher than that in HV. In the absolute number of Th2 cells: [EB 1651(6033) No significant difference in sputum Th2 cell level was found between EB and EA (P>0.05).
is a rare pulmonary disease that mainly affects the lungs, kidneys, and retroperitoneum, with typical manifestations include dyspnea, pneumothorax, diffuse cystic changes in the lungs, which severely affect lung function, especially diffuse function.
Methods:
We retrospectively collect data of lung function tests of LAM patients consulted in Guangzhou Institute of Respiratory Disease from 2014 to 2018, and analyzed the characteristics of pulmonary function.
Results: A total of 69 LAM patients were included, and the data were analyzed. The patients were females with mean age 37.6 AE 9.4 years old.
For the results of spirometry, 9 cases (13%) were normal, 5 (7%) According to results of spirometry, LAM patients were divided into normal group (n = 9), restrictive group (n = 5), light-moderate obstructive group (n = 33), and severe-very severe obstructive group (n = 22), and the diffusion function were DLCO 67.6 AE 21.9, 66.2 AE 11.8, 47.0 AE 17.5, 34.1 AE 10.4, DLCO/VA 70.2 AE 17.8, 88.0 AE 15.7, 52.3 AE 21.0, 40.4 AE 15.0, respectively.
Conclusion:
The pulmonary function of LAM patients is mainly obstructive (gas traps exist in some patients), and the diffusion function is significantly reduced. Even in some patients with normal pulmonary function of spirometry, the diffusion function has been mild to moderate impaired, suggesting that the diffusion function was significantly impaired and it happened earlier than the impairment of spirometry in LAM. 
